Interferon-α2b Treatment for COVID-19

Interferon-α2b Treatment for COVID-19

The global pandemic of COVID-19 cases caused by infection with SARS-CoV-2 is ongoing, with no approved antiviral intervention. We describe here the effects of treatment with interferon (IFN)-α2b in a cohort of confirmed COVID-19 cases in Wuhan, China. In this uncontrolled, exploratory study, 77 adul...

Full description

Bibliographic Details
Main Authors:	Qiong Zhou, Virginia Chen, Casey P. Shannon, Xiao-Shan Wei, Xuan Xiang, Xu Wang, Zi-Hao Wang, Scott J. Tebbutt, Tobias R. Kollmann, Eleanor N. Fish
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-05-01
Series:	Frontiers in Immunology
Subjects:	interferon COVID-19 viral shedding IL-6 inflammation ARDS
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.01061/full

Similar Items

Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities
by: Qiong Zhou, et al.
Published: (2020-12-01)

Polymorphism in interferon alpha/beta receptor contributes to glucocorticoid response and outcome of ARDS and COVID-19
by: Juho Jalkanen, et al.
Published: (2023-03-01)

Efficacy and safety of triple therapy with recombinant interleukin-1β, recombinant interferon-α and ribavirin in patients with chronic hepatitis C, genotype 1 infection, the non-responders to previous treatment with interferon and ribavirin
by: Yu. V. Lobzin, et al.
Published: (2014-09-01)

The COVID-19 Cytokine Storm; What We Know So Far
by: Dina Ragab, et al.
Published: (2020-06-01)

Respiratory syncytial virus NS1 inhibits anti-viral Interferon-α-induced JAK/STAT signaling, by limiting the nuclear translocation of STAT1
by: Claudia Efstathiou, et al.
Published: (2024-06-01)

Induction of the pro-myelocytic leukaemia gene by type I and type II interferons
by: M. Heuser, et al.
Published: (1998-01-01)

Lentiviral interferon: A novel method for gene therapy in bladder cancer
by: Sharada Mokkapati, et al.
Published: (2022-09-01)

Investigation of the relationship between type I (α,β) interferon and viral load in patients with Crimean-Congo haemorrhagic fever (CCHF)
by: I. Büyükhan S, et al.
Published: (2024-09-01)

Progress in cytokine research for ARDS: A comprehensive review
by: Zhou Kaihuan, et al.
Published: (2024-10-01)

Interleukin-6 and Interferon-α Signaling via JAK1–STAT Differentially Regulate Oncolytic versus Cytoprotective Antiviral States
by: Oded Danziger, et al.
Published: (2018-01-01)

Role of interferon regulatory factors in predicting the prognosis of Crimean-Congo hemorrhagic fever
by: Öksüz Caner, et al.
Published: (2024-12-01)

Interferon β-1a ring prophylaxis to reduce household transmission of SARS-CoV-2: a cluster randomised clinical trialResearch in context
by: José A. Castro-Rodriguez, et al.
Published: (2023-08-01)

Oromucosal Administration of Interferon to Humans
by: Manfred W. Beilharz, et al.
Published: (2010-01-01)

CMV on surfaces in homes with young children: results of PCR and viral culture testing
by: Minal M. Amin, et al.
Published: (2018-08-01)

The Alzheimer’s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130
by: Stephan A. Müller, et al.
Published: (2023-02-01)

Interference without interferon: interferon-independent induction of interferon-stimulated genes and its role in cellular innate immunity
by: Shachee Swaraj, et al.
Published: (2024-10-01)

How Many Mammalian Reovirus Proteins are involved in the Control of the Interferon Response?
by: Delphine Lanoie, et al.
Published: (2019-06-01)

Protection of Ducklings from Duck Hepatitis A Virus Infection with ELPylated Duck Interferon-α
by: Yongjuan Wang, et al.
Published: (2022-03-01)

Interferon lambda in respiratory viral infection: immunomodulatory functions and antiviral effects in epithelium
by: Yong-Guang Liu, et al.
Published: (2024-03-01)

Editorial: Identification, function and mechanisms of interferon induced genes associated with viruses
by: Linzhu Ren, et al.
Published: (2023-01-01)

Analysis of the association between subjective sleep quality and the duration of viral shedding in patients with COVID-19: A cohort study
by: Chengyong Liu, et al.
Published: (2023-12-01)

Interferon Induction by RNA Viruses and Antagonism by Viral Pathogens
by: Yuchen Nan, et al.
Published: (2014-12-01)

Interferon-λ in HCV Infection and Therapy
by: Michael D. Robek, et al.
Published: (2010-08-01)

Functional Involvement of Interferon-Inducible Transmembrane Proteins in Antiviral Immunity
by: Yuan Liao, et al.
Published: (2019-05-01)

The therapeutic efficacy of cycloferon and the pharmacological activity of interferon inhibitors
by: M G Romantsov, et al.
Published: (2014-01-01)

Association of IL28B Genotypes and Baseline Serum Interferon-γ-Inducible-Protein-10 Levels with Treatment Response in Hepatitis C Virus Patients in China
Published: (2016-05-01)

Autoantibodies before, during and after administration of recombinant interferon-alpha for chronic viral hepatitis Estudo dos auto-anticorpos nas Hepatites virais crônicas B e C antes, durante e após tratamento com Interferon-alfa
by: Edmundo P.A. Lopes, et al.
Published: (1995-10-01)

Inflammatory and interferon gene expression signatures in patients with mitochondrial disease
by: Emily B. Warren, et al.
Published: (2023-05-01)

DDX6 Represses Aberrant Activation of Interferon-Stimulated Genes
by: Jennifer H. Lumb, et al.
Published: (2017-07-01)

Type-I interferon pathway and DNA damage accumulation in peripheral blood of patients with psoriatic arthritis
by: George E. Fragoulis, et al.
Published: (2023-12-01)

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
by: Megen C. Wittling, et al.
Published: (2021-01-01)

Type I interferon signaling in dendritic cells limits direct antigen presentation and CD8+ T cell responses against an arthritogenic alphavirus
by: Christopher B. Bullock, et al.
Published: (2024-12-01)

Effects of interferon therapy onfunctional activity of platelets in chronic viral hepatitis andcirrhosis of the liver
by: A V Yagoda, et al.
Published: (2004-08-01)

Use of Recombinant α-2b-Interferon in the Treatment of Acute Respiratory Viral Diseases in Children
by: O.Ye. Chernyshova
Published: (2016-09-01)

Interferon-Gamma: Treatment Horizons
by: A. A. Khryanin, et al.
Published: (2020-05-01)

The Emergence of Saliva as a Diagnostic and Prognostic Tool for Viral Infections
by: Nilson Ferreira de Oliveira Neto, et al.
Published: (2024-11-01)

Clinical and virological characteristics of viral shedding in children with norovirus gastroenteritis
by: Chung-Chan Lee, et al.
Published: (2022-12-01)

Interferon-Responsive Genes Are Targeted during the Establishment of Human Cytomegalovirus Latency
by: Elizabeth G. Elder, et al.
Published: (2019-12-01)

Viral load in interferon treated & untreated patients of HCV
by: Alamzeb Jadoon, et al.
Published: (2023-08-01)

The cytokines interleukin-6 and interferon-α induce distinct microglia phenotypes
by: Phillip K. West, et al.
Published: (2022-04-01)